TGF-&bgr; Pathway as a Therapeutic Target in Bone Metastases

E-ISSN： 1873-4286|16|11|1301-1312

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.11, 2010-04, pp. : 1301-1312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TGF-&bgr;: Its Role in Asthma and Therapeutic Potential

Current Drug Targets, Vol. 7, Iss. 5, 2006-05 ,pp. : 547-565

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and Invertebrates: TGF-&bgr; and PDGF

Current Pharmaceutical Design, Vol. 12, Iss. 24, 2006-08 ,pp. : 3025-3031

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the TGF-&bgr; Superfamily and their Clinical Applications

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1255-1261

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Tolerance and TGF-&bgr; -Producing Cells

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-01 ,pp. : 179-190

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-&bgr;, Eosinophils and IL-13 in Allergic Airway Remodeling: A Critical Appraisal with Therapeutic Considerations

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 4, 2008-12 ,pp. : 224-236

Bentham Science Publishers

Access to resources Recommend Favorite